|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.11 CHF | -0.42% |
|
+0.50% | +9.85% |
| 12:46pm | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 09:06am | The V for victory, at least on the charts |  |
| Capitalization | 292B 250B 230B 217B 404B 27,360B 414B 2,696B 1,060B 13,066B 1,097B 1,073B 46,674B | P/E ratio 2026 * |
21.2x | P/E ratio 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise value | 326B 278B 256B 242B 450B 30,484B 461B 3,004B 1,181B 14,558B 1,222B 1,196B 52,003B | EV / Sales 2026 * |
5.7x | EV / Sales 2027 * | 5.32x |
| Free-Float |
87.19% | Yield 2026 * |
2.88% | Yield 2027 * | 3.01% |
Last Transcript: Novartis AG
| 1 day | -0.35% | ||
| 1 week | +0.50% | ||
| Current month | -0.38% | ||
| 1 month | -0.86% | ||
| 3 months | +3.74% | ||
| 6 months | +15.72% | ||
| Current year | +9.85% |
| 1 week | 120.12 |  | 123.62 |
| 1 month | 113.64 | | 123.62 |
| Current year | 107.68 | | 131 |
| 1 year | 87.89 | | 131 |
| 3 years | 81.1 | | 131 |
| 5 years | 72.84 | | 131 |
| 10 years | 65.09 | | 131 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 01/02/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 16/03/2026 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 16/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 68 | 01/01/2015 |
| Director/Board Member | 69 | 01/01/2016 | |
Ton Büchner
BRD | Director/Board Member | 61 | 01/01/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 10.4% | 121 M€ | |
| -0.16% | 5.57% | 26 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.42% | +0.50% | +35.68% | +37.68% | 292B | |
| -1.06% | +0.27% | +26.92% | +147.78% | 832B | |
| -0.21% | -1.25% | +56.83% | +43.25% | 573B | |
| -0.71% | -0.11% | +17.95% | +26.91% | 365B | |
| +0.27% | -0.75% | +29.45% | +14.12% | 322B | |
| -0.57% | -0.08% | +44.83% | +25.68% | 313B | |
| -1.05% | -0.58% | +51.74% | +3.95% | 297B | |
| -0.34% | +2.12% | +22.32% | +39.13% | 189B | |
| +0.03% | -0.78% | +34.16% | +66.96% | 173B | |
| +3.32% | +4.93% | -43.40% | -56.89% | 166B | |
| Average | +0.14% | -0.52% | +27.65% | +34.86% | 352.05B | |
| Weighted average by Cap. | +0.07% | -0.60% | +32.30% | +54.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.11B 48.79B 44.99B 42.46B 78.89B 5,348B 80.9B 527B 207B 2,554B 214B 210B 9,123B | 60.48B 51.67B 47.64B 44.96B 83.55B 5,663B 85.67B 558B 219B 2,705B 227B 222B 9,661B |
| Net income | 14.13B 12.07B 11.13B 10.51B 19.52B 1,323B 20.02B 130B 51.26B 632B 53.04B 51.91B 2,257B | 15.72B 13.43B 12.38B 11.68B 21.71B 1,472B 22.26B 145B 57B 703B 58.98B 57.73B 2,510B |
| Net Debt | 33.36B 28.5B 26.28B 24.8B 46.08B 3,124B 47.25B 308B 121B 1,492B 125B 123B 5,329B | 29.77B 25.43B 23.45B 22.13B 41.12B 2,787B 42.16B 275B 108B 1,331B 112B 109B 4,755B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/04/26 | 120.42 CHF | -0.17% | 396,488 |
| 13/04/26 | 120.62 CHF | -0.94% | 1,853,656 |
| 10/04/26 | 121.76 CHF | -0.34% | 2,149,505 |
| 09/04/26 | 122.18 CHF | +0.83% | 2,251,811 |
| 08/04/26 | 121.18 CHF | +1.15% | 3,324,703 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition